Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
3.98M
-
Shares change
-
+3.97M
-
Total reported value, excl. options
-
$16.5M
-
Value change
-
+$16.5M
-
Number of buys
-
46
-
Number of sells
-
-1
-
Price
-
$4.14
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2016
48 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q2 2016.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.98M shares
of 79.8M outstanding shares and own 4.99% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (904K shares), BlackRock Fund Advisors (745K shares), NORTHERN TRUST CORP (293K shares), STATE STREET CORP (221K shares), BlackRock Institutional Trust Company, N.A. (201K shares), GEODE CAPITAL MANAGEMENT, LLC (172K shares), Coe Capital Management, LLC (165K shares), GOLDMAN SACHS GROUP INC (149K shares), Granite Investment Partners, LLC (136K shares), and BlackRock Investment Management, LLC (111K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.